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197X---The role of the renin-angiotensin system and prostaglandins in renal autoregulation was investigated in dog kidneys in situ. Renal autoregulation during decreases in renal arterial pressure (RAP) was examined in animals pretreated with a competitive antagonist of angiotensin II, [ I-sarcosine, 8-glycine] angiotensin II, or one of two chemically dissimilar inhibitors of prostaglandin synthetase, indomethacin and meclofenamate. Because of recent evidence suggesting a role for an intrarenal beta receptor in regulating renin release, renal autoregulation was also examined in animals treated with the beta-adrenergic blocking agent propranolol. In all groups of animals constancy of glomerular filtration rate (GFR) and renal blood flow (RBF) was observed after substantial decreases in RAP to a range of 70-90 mmHg. These studies therefore do not provide evidence in support of a role for angiotensin II, prostaglandins, or an intrarenal beta receptor as mediators of the renal autoregulation of GFR or total RBF.
renal blood flow; glomerular filtration rate; renin-angiotensin system; prostaglandins; beta blockers THE MECHANISM OF RENAL AUTOREGULATION remains the center of considerable controversy. The effect of papaverine to abolish renal autoregulation has been used to support the myogenic theory of renal autoregulation in which transmural tension across the afferent arteriole is proposed as the determinant of the relative state of vascular tone (37). Alternatively, smooth muscle paralysis with papaverine could render the afferent arteriole unresponsive to any intrarenal humoral substance that is involved in renal autoregulation. The renin-angiotensin system has been the humoral mechanism rnost frequently proposed to be involved in renal autoregulation (34, 35) . Evidence obtained with the use of microperfusion techniques has been reported that suggests that the concentration of sodium at the macula densa cells in the distal convoluted tubule may determine both the rate of glomerular filtration (7, 38) and the concentration of renin in juxtaglomerular cells (36) of the same nephron. However, using similar microperfusion techniques other investigators have failed to find any evidence for such a tubuloglomerular feedback mechanism (28, 29) . Moreover, there is some circumstantial evidence against invoking the renin-angiotensin system in renal autoregulation.
In contrast to previous pro posals (34)) a high-sodium diet with or without exogenous mineralocorticoid for 5-7 wk has been shown not to affect autoregulation of renal blood flow (RBF) (4, 12) or glomerular filtration rate (GFR) (12, 28) in the in situ nonperfused dog kidney. There is no ready explanation why a high-sodium intake and mineralocorticoid administration have been reported to blunt renal autoregulation in the isolated perfused dog kidney (18) and in situ perfused kidney (6). Other circumstantial evidence against the renin-angiotensin system as the regulator of renal autoregulation is the finding that renal venous (11, 26) On the day of the study the animals were anesthe-tized with intravenous pentobarbital (30 mg/kg), then intubated and ventilated with a Harvard respirator (Harvard Apparatus Co. Inc., Millis, Mass.). Supplemental doses of pentobarbital were administered as needed throughout the experiment to maintain a stable state of anesthesia. Polyethylene catheters were placed in both ureters and renal veins through bilateral flank incisions made by retroperitoneal approach. A Blalock clamp was placed around the aorta above both renal arteries to allow alteration in renal arterial pressure (RAP). Catheters were placed in the brachial and femoral arteries to obtain blood samples and to allow monitoring of arterial blood pressure above and below the aortic clamp with Statham transducers (Statham Instruments Inc., Oxnard, Calif.). A 0.9 % sodium chloride solution containing sufficient inulin and p-aminohippurate (PAH) was infused (0.5 ml/mm) into a forearm vein to maintain plasma levels of these substances at 15-20 mg/lOO ml and l-3 mg/ 100 ml, respectively. To allow replacement of fluid losses and adequate urine flows for accurate clearance measurements 2.5 % dextrose was infused intravenously at 10 ml/ min for 50 min during surgery. Thirty minutes after completion of surgery an additional 600 ml of 2.5 % dextrose were administered at 10 ml/min and then the infusion rate was adjusted to equal urine flow rate.
In the propranolol (group Z), indomethacin (groz@ ZZZ), and meclofenamate (group IV) studies three urine collections 5-10 min in duration were made before and after administration of these agents. The postdrug urine collections were made after a 20-to 300min equilibration period after drug administration and served as the control periods for the periods during the first lowering of RAP by aortic constriction. In the angiotensin II inhibitor studies (group ZZ) the pressor response to 500 ng of angiotensin II was examined before and after administration of the inhibitor. Three control urine collections then were obtained prior to the aortic constriction periods.
In all studies RAP was lowered in 20-to 25mmHg decrements. After each decrement an equilibration period of 15-30 min was allowed before blood and urine samples were collected. Arterial and renal venous samples were obtained at the midpoint of alternate urine collections. In all studies two or three sequential aortic clamping periods were obtained in each animal prior to the aortic clamp release. The urine collections during the first clamping period were complete for gruups I-IV within 1 h after drug administration. All sequential clamping periods were complete for groups I-IV within 2 h of drug administration.
In some indomethacin studies (group ZZZ) renal blood flow was determined by a square-wave electromagnetic flow probe placed around a renal artery (Carolina Medical Electronics, King, N.C.) . In these studies a zero base line was obtained prior to the studies by temporary occlusion of the renal artery.
GTOU~~ Z-jwopanolol studies. In these studies the effect of beta-adrenergic blockade on renal autoregulation was examined when propranolol, 2 mg/kg (4 dogs) or 4 mg/kg (2 dogs), was administered by intravenous injection and then propranolol, 0.4 mg/kg per h, in 0.9 % sodium chloride solution was infused intravenously at 0.5 ml/mm throughout the experiment. After 30 min and stabilization of urine flow three to five control periods were obtained; RAP then was decreased 20-25 mmHg by adjustment of the suprarenal aortic clamp. Experimental collections for three to five periods were commenced after a 20-to 300min equilibration period at the lower RAP. In most animals a second, and occasionally a third, lowering of RAP by another 20-30 mmHg was accomplished and after another equilibration experimental collections again were made. Urine collections were also made after release of the aortic clamp. During the control period and with each alteration in RAP plasma renin activity (PRA) was measured by the radioimmunoassay technique of Stockigt, Collins, and Biglieri (32).
Group ZI-angiotensin inhibitor studies. In five dogs renal autoregulation was examined during the infusion of [ l-sarcosine, 8-glycinelangiotensin II, a substance known to be a competitive inhibitor of angiotensin II (22) and obtained from Dr. D. Regoli, Sherbrooke, Quebec. This angiotensin inhibitor was infused at 0.5 ml/min iv (4 dogs) or into the aorta just above orifices of the renal arteries (1 dog) at a rate of 1 pg/kg per min in a 0.9 % sodium chloride solution. The same protocol described in the group Z studies to examine the effects of increasing and decreasing RAP was also used in these group ZZstudies.
Croup ZZZ-indomeihacin studies. In eight dogs renal autoregulation was examined after inhibition of prostaglandin synthesis with a single intravenous injection of indomethacin in a dose of either 2 mg/kg (6 dogs) or 10 mg/kg (2 dogs). The same protocol described for the group Z studies was used in these experiments. In five dogs a 2-mg/kg dose of indomethacin was injected intravenously at the time of each reduction in renal perfusion pressure. Urine and blood collections were then started within 15 min of indomethacin administration. In an additional five dogs, renal autoregulation was examined with an electromagnetic flow probe after either 1 0-mg/kg (2 dogs) or 20-mg/kg (3 dogs) doses of indomethacin.
Group IV-meclofenamate studies. Renal autoregulation was examined in these studies (4 dogs) in the presence of inhibition of prostaglandin synthesis with meclofenamate in a 2-mg/kg intravenous bolus followed by a constant infusion of 2 mg/kg per h in 0.9 % sodium chloride solution at a rate of 0.5 ml/min. Otherwise the same protocol described for the group Z studies was used in these experiments.
The calculations used in the present experiments have been discussed elsewhere (30). p-Aminohippurate was determined by the method of Bratton and Marshall as adapted for the Technicon AutoAnalyzer (14). Inulin was determined calorimetrically by reaction with anthrone in H&04 (8) by a technique adapted for the Technicon AutoAnalyzer (9). The analysis of variance was used when several values were involved and the paired Student t test when two values were involved. A P value of <0.05 was considered significant. All data are expressed as means & SE.
RESULTS E$ect of popranolol on renal autoregulation (Fig. I) . The results for the studies in group Z were similar for both doses of propranolol used; the results therefore were analyzed together. In these studies control measurements of renal hemodynamics were made before and after the administration of-propranolol. There was no significant difference in mean arterial pressure (MAP) before (132 & 5 mmHg) and after (127 & 5 mrnHg) administration of propranolol. However, three animals did become profoundly hypotensive after propranolol administration and therefore were not used for the study. Glomerular filtration rate and RBF also were not altered by beta-adrenergic blockade with intravenous propranolol; GFR was 49 rf= 4 before and 50 & 5 ml/mm after propranolol and RBF was 215 =t 20 and 207 & 23 ml/min, respectively. In addition, renal vascular resistance (RVR) did not significantly change after propranolol (0.656 & 0.062 before and 0.645 h 0.056 mmHg/ml per min after propranolol).
The results in the group Z experiments for serial decrements in RAP on GFR and RBF are shown in Fig. 1 per min) also were not significantly different from control values after release of the aortic clamp. The mean RVR for all periods both before clamping and after clamp release was 0.642 =t 0.060 mmHg/ml per min. This value was significantly higher than the RVR of0.416 & 0.037 mmHg/ml per min (P < 0.001) that was present when RAP was decreased to 79 & 1 mmHg by aortic clamping. After propranolol administration PRA decreased from 32.4 =f= 8 to 10.6 =t 3 rig/ml per h (P < 0.02). A decrease in RAP from 127 =t 5 to 104 j, 3 mmHg was associated with an increase' in PRA from 10.6 =t 3 to 15.9 =f= 4 rig/ml per h (P < 0.1) and a further decrease in RAP to 79 =t 1 mmHg increased PRA to 23.7 =t 5 rig/ml per h (P < 0.05). Release of the clamp was associated with a decrease in PRA to 10.4 A 3 rig/ml per h, a value sigGlomerular '"1 7
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Rate 5O (ml/min) nificantly below (P < 0.005) the PRA of 23.7 & 5 rig/ml per h prior to clamp release.
EJect of angiotensin ZZ inhibitor on renal autoregulation (Fig. 2) .
Prior to infusion of the inhibitor, 500 ng of angiotensin II increased blood pressure by 27 =t 4 mmHg; the same dose of angiotensin II did not alter blood pressure after infusion of the inhibitor. The effect of the angiotensin inhibitor on the renal vascular response to 500 ng of angiotensin II also was tested in eight experiments performed on four kidneys. In these experiments, 500 ng of intravenous angiotesin II resulted in a significant decrease in RBF as determined by electromagnetic flow probe (253 & 28 to 209 h 29 ml/min, P < 0.001). However, in the same animals undergoing an intravenous infusion of 1 rg/kg per min of [l-sarcosine, 8-glycinelangiotensin II, the same dose of angiotensin II did not affect RBF (243 =t 25 to 242 =t 24 ml/min). The results in the group ZZ experiments for serial decrements in RAP on GFR and RBF are shown in Fig. 2 . No significant changes occurred in GFR or RBF at any level of RAP. There was no significant change in GFR (51 =t 2 to 57 =t 3 ml/min) or MAP (149 & 3 to 137 & 4 mmHg) when values before aortic clamping and after aortic clamp release were compared. There was, however, a significant increase in RBF from 250 AZ 21 to 336 zt 18 ml/ min (P < 0.01) when preclamp and clamp-release values were compared. We have no ready explanation for this increase. The mean RVR for all periods before aortic clamping and after clamp release was 0.456 & 0.030 mmHg/ml per min and, as RAP was decreased to 88 =t 3 mmHg, RVR fell significantly to 0.274 =f= 0.026 mmHg/ml per min (P < 0.001). The RBF was generally higher in the group treated with angiotensin inhibitor than in other groups because all animals except one were greyhounds with high hematocrits. EJect of indom&acin on renal autoregulation (Fig. 3) (Fig. 4) . In these studies, 2 mg/kg of meclofenamate resulted in a significant increment in MAP (146 & 6 to 160 * 8 mmHg, P < 0.05) and RVR (0.600 & 0.072 to 0.789 ZJZ 0.096 mmHg/ml per min, P < 0.05) as RBF decreased (227 & 17 to 180 & 18 ml/min, P < 0.001) in the three animals' in which the measurements were made. Serial decrements in RAP produced little change in GFR or RBF in the meclofenamate-treated animals (Fig. 4) . No significant differences in GFR or RBF at any level of RAP were present. There were no significant changes in GFR ( 
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DISCUSSION
In the present study several methods were used to investigate the potential role of humoral mediators in the autoregulation of GFR and RBF. In one group of studies beta- (11, 26) an inverse, rather than a direct, relationship was found between RVR and PRA. These results also confirm the findings of other investigators that renin release may occur as RVR decreases (10) and thus as the stretch on any intrarenal baroreceptor controlling renin release presumably increases (5). These findings original proposal that a fall are therefore in contrast to the in renal perfusion pressure increases renin release bY decreasing stretch on an intr 'arena1 vascula r receptor (3 1 is inhibited longer than 1 h after a lmg/kg iv dose of meclofenamate and is depressed by 50 % at 3 h after a single I-or 2-mg/kg iv dose of indomethacin (2). Finally, using a specific radioimmunoassay, recent investigators have demonstrated that a single 2-mg,/kg iv dose of indomethacin significantly depresses prostaglandin El in renal venous blood for more than 2.5 h (40).
In the present study the preservation of autoregulation of GFR and RBF was demonstrated at 1 and 2 h after treatment with indomethacin (Z-20 mg/kg). Also studies were performed in which RAP was lowered immediately after indomethacin administration and renal autoregulation was similarly present in these studies. Large doses of meclofenamate (2 mg/kg plus 2 mg/kg per h) also failed to alter autoregulation of GFR and RBF in the present studies. On the basis of previous studies (2, 15, 21, 40) there can be little doubt that autoregulation was tested in the present study in the presence of substantial inhibition of prostaglandin synthesis.
The present studies therefore indicate that renal autoregulation of GFR and total RBF is not altered in the in situ kidney by rather large doses of two chemically dissimilar inhibitors of prostaglandin synthetase. These results are compatible with the findings reported in three recent preliminary communications in which no significant alteration in autoregulation of RBF occurred in the presence of inhibition of prostaglandin sYn .thesis (1, 24, 25) . Although prostaglandin release may not be a significant determinant of autoregulation of total RBF, some disturbance of autoregulation of medullary blood flow may occur after prostaglandin inhibition (24). Also in this regard, inhibitors of prostaglandin synthesis have been show to decrease inner cortical blood flow (17, 19, 24) . Finally, there is also some evidence that
